TCTC Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Hold |
202
| – | – | ﹤0.01% | 257 |
|
|
2025
Q1 | $128K | Hold |
202
| – | – | ﹤0.01% | 235 |
|
|
2024
Q4 | $144K | Hold |
202
| – | – | 0.01% | 227 |
|
|
2024
Q3 | $212K | Hold |
202
| – | – | 0.01% | 198 |
|
|
2024
Q2 | $212K | Hold |
202
| – | – | 0.01% | 195 |
|
|
2024
Q1 | $194K | Hold |
202
| – | – | 0.01% | 190 |
|
|
2023
Q4 | $177K | Hold |
202
| – | – | 0.01% | 197 |
|
|
2023
Q3 | $166K | Hold |
202
| – | – | 0.01% | 193 |
|
|
2023
Q2 | $145K | Hold |
202
| – | – | 0.01% | 203 |
|
|
2023
Q1 | $166K | Hold |
202
| – | – | 0.01% | 201 |
|
|
2022
Q4 | $146K | Hold |
202
| – | – | 0.01% | 200 |
|
|
2022
Q3 | $139K | Hold |
202
| – | – | 0.01% | 197 |
|
|
2022
Q2 | $119K | Hold |
202
| – | – | 0.01% | 211 |
|
|
2022
Q1 | $141K | Hold |
202
| – | – | 0.01% | 212 |
|
|
2021
Q4 | $128K | Sell |
202
-20
| -9% | -$12.7K | 0.01% | 240 |
|
|
2021
Q3 | $134K | Hold |
222
| – | – | 0.01% | 220 |
|
|
2021
Q2 | $124K | Hold |
222
| – | – | 0.01% | 211 |
|
|
2021
Q1 | $105K | Buy |
+222
| New | +$105K | 0.01% | 221 |
|